Xcout IntelCalciMedica, Inc.
CalciMedica, Inc., a clinical-stage biotechnology company headquartered in La Jolla, California, is focused on creating treatments for life-threatening inflammatory diseases that currently lack adequate therapies. The company's proprietary approach involves blocking calcium release-activated (CRAC) channels, a mechanism designed to modulate the immune system and protect against cellular and tissue damage in these severe conditions. Their primary experimental drug, Auxora, is an intravenously administered, proprietary CRAC channel inhibitor being developed for the treatment of acute pancreatitis, including its asparaginase-associated form, and acute kidney injury.
Subscribe to see CalciMedica, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
CalciMedica, Inc. at a glance
CalciMedica, Inc. is a biotech company headquartered in La Jolla, United States, founded in 2006. It is publicly listed (CALC) with a market capitalisation of $6M. Xcout tracks 19 named people at CalciMedica, Inc., including A. Rachel Leheny (Chief Executive Officer & Director).
CalciMedica, Inc. leadership
- A. Rachel LehenyChief Executive Officer & Director
- Michael J. DunnPresident & Chief Operating Officer
- Stephen BardinChief Financial Officer
- Sudarshan HebbarChief Medical Officer
- Eric W. RobertsChief Business Officer & Vice Chairman of the Board
- Kenneth A. StaudermanCo-Founder & Chief Scientific Officer
13 more named people on record for CalciMedica, Inc., with roles, board committees and tenure — see the full roster →
CalciMedica, Inc. funding rounds on record
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $9M | — | |
| Series B | $5.5M | — |
Some filings are not shown as funding rounds.
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Get CalciMedica, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on CalciMedica, Inc. in Xcout Intel
- 19 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- 2 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access